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A controlled clinical trial was undertaken to compare the efficacy of short course chemotherapy
given alone or combined with radical surgery in the treatment of spinal tuberculosis without
paraplegia. Patients with active spinal tuberculosis involving the vertebral bodies and without
paraplegia were randomly allocated to one of the following three regimens.
(a) Rad 6 : Radical anterior resection with bone grafting plus six months of daily isoniazid
and rifampicin.
(b) Amb 6 : Ambulatory chemotherapy with six months of daily isoniazid and rifampicin, without
surgery.
(c) Amb 9 : Same as (b) but the duration being nine months.
The patients were intensively followed up for five years from the start. At five years, 98% of
86 Amb 9, 91% of 82 Amb 6 and 88% of 82 Rad 6 patients had a favourable status. It is concluded
that ambulatory chemotherapy for 6 or 9 months is highly effective in the treatment of spinal
tuberculosis. Radical surgery did not enhance the efficacy of the short course regimen.
Controlled clinical trials of the Medical Research Council
Working Party on Tuberculosis of the Spine clearly showed
that ambulatory out-patient chemotherapy with daily
isoniazid plus PAS for 18 months was highly effective
in the treatment of spinal tuberculosis (MRC- 1973 a and
b, 1974 a, 1976, 1978, 1985). Further, there was no
additional benefit because of rest in bed (MRC-1973 a,
1976, 1985), or a plaster-of-Paris jacket (MRC-1973 b,
1976, 1985), or a simple debridement operation (MRC-
1974 a, 1978). On the contrary, the modified Hong Kong
operation (i.e. radical resection of the tuberculous focus
and anterior spinal fusion) was not only highly effective
but also conferred special benefits, namely early healing
by bony fusion, less spinal deformity and rapid resolution
of mediastinal abscesses (MRC-1974 b, 1978). However,
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it is a major surgical procedure requiring surgical ex-
pertise, efficient nursing, excellent anaesthetic facility
and bundant resources, which are not widely available
in developing countries.
Short course regimens based on isoniazid and rifampicin
for 6-9 months have been shown to be highly effective
in sputum positive pulmonary tuberculosis (BMRC-1974
and 1976; Fox, 1981; IUAT, 1988), and the bacillary
population in spinal disease is much smaller than in
pulmonary lesions (Canetti et al, 1957; Debeaumont,
1966). Hence a controlled clinical trial was undertaken
in Madras, India, in collaboration with British Medical
Research Council Working Parties on Tuberculosis of
the Spine to compare the efficacies of 6 or 9 months
of ambulatory chemotherapy with isoniazid plus rifampicin
daily and radical surgery plus the above chemotherapy
for 6 months on an out-patient basis. The findings up
to 3 years have already been reported (ICMR, 1989).
Results up to 5 years are presented here.
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MATERIAL AND METHODS
Eligibility Criteria for Admission to Study
Patients with clinically and radiographically active spinal
tuberculosis involving any vertebral body from the first
thoracic to the first sacral, inclusive, were eligible for
admission to the study. Patients were ineligible if they
had (a) paralysis of the lower limbs severe enough to
prevent them from walking across a room (about 6 meters),
(b) serious extra-spinal disease, tuberculous or non-tu-
berculous, (c) a history of previous chemotherapy for 12
months or more, or (d) already had major surgery for
their spinal tuberculosis.
Pre-treatment Investigations
Investigations on admission included the following:
(a) Complete clinical (including neurological) examina-
tion, (b) antero-posterior (A-P) and lateral radiographs
of the whole spine and a posteo-anterior (P-A) radiograph
of the chest, (c) examination by culture of(i) two specimens
of pus from any abscess or sinus, if present and (ii) 3
sputum specimens from patients with radiographic ev-
idence of pulmonary tuberculosis and (d) sensitivity tests
to isoniazid and rifampicin on positive cultures of M.
tuberculosis.
Allocation to Treatment
Each patient was allocated at random to one of the
following 3 treatment series :
(a) Rad 6 : Radical anterior resection with bone grafting
plus isoniazid and rifampicin in 1 dose
daily for 6 months.
(b) Amb 6 : Ambulatory treatment with isoniazid and
rifampicin in 1 dose daily for 6 months.
(c) Amb 9 : Same as (b), but the duration being 9
months.
The dosages were 5-7 mg/kg body-weight for isoniazid
and 10-15 mg/kg for rifampicin (ICMR-1989).
Assessment of Progress
Progress was assessed at 6 monthly intervals from 3-5
years and was based on : (1) clinical (including neuro-
logical) examination, (2) A-P and lateral radiographs of
the vertebrae involved, and a P-A radiograph of the chest
if lungs were affected prior to admission, and (3) bac-
teriological examination of pus from any sinus or abscess,
and of sputum from patients with pulmonary tuberculosis.
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RESULTS
Study Population
In all, 304 (100 Rad 6, 101 Amb 6, 103 Amb 9) patients
w re admitted to the study. For various reasons, 54 (18
Rad 6, 19 Amb 6, 17 Amb 9) patients were excluded
from analyses. The reasons for the exclusions of 44
patien s were given in the 3-year report (ICMR-1989).
The other ten patients (3 Rad 6, 1 Amb 6, 6 Amb 9)
were excluded during the 3-5 year period because 5
(1 Rad 6, 4 Amb 9) died of non-tuberculous causes, 4
(2 Rad 6, 2 Amb 9) had additional treatment for extra-
spinal tuberculosis and 1 (Amb 6) was lost to follow-
up; thus, there remained 250 (82 Rad 6, 82 Amb 6, 86
Amb 9) patients in the analyses.
Intensity of Follow-up
the intensity of follow-up examinations during the 5 years
was very high and similar in the 3 series. Thus, 99.5%
of the Rad 6 and 100% of the combined Amb series
patients were examined at 2 years after the start of
treatment. The corresponding figures at 3 years were
98.5% and 98.8%, respectively, and at 5 years they were
97.9% and 100%, respectively. This has been achieved
because of intensive efforts made by the staff to retrieve
defaulters (Thilakavathi et al, 1993).
Pre-treatment Characteristics
The distributions of the clinical, radiographic and bac-
teriological findings before the start of treatment were
broadly similar for the 2 series (Table 1). In brief, 34%
of the 250 patients were aged less than 15 years and 25%
were aged 35 years or more; 20% had a sinus and/or
clinically evident abscess, 84% had an obvious kyphosis
and 50% had lesions at the thoracic or thoraco-lumbar
regions of the spine.
Deaths
Four patients (all Rad 6) died due to reasons associated
with spinal tuberculosis, including 2 in the immediate
post-operative period (ICMR-1989).
Modification of the Allocated Treatment
Major modifications were made to the allocated regimen
in 11 patients (5 Rad 6, 5 Amb 6, 1 Amb 9). Of the
5 Rad 6 patients, the operation was abandoned in 2, the
third had a second operation because of posterior dis-
placement of the graft, the fourth had the graft removed
for a persistent post-operative sinus and the fifth had
additional drugs for myelopathy with complete paralysis,
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and died in the 5th month. Of the ambulatory series
patients; 4 (3 Amb 6, 1 Amb 9) had decompression
surgery because of myelopathy with increasing functional
impairment and 2 (both Amb 6) had additional chemo-
therapy because they developed clinically evident ab-
scesses.
Table 1 : Pre-treatment characteristics
Percentage of patients
Pretreatment characteristics
Rad 6 Amb 6 Amb 9 Total
Age (years)
0 - 4 11 17 13 14
5 - 1 4 20 27 14 20
15 -34 43 39 43 42
35 -54 26 13 26 22
55 or more 1 4 5 3
Sinus and/or clinically-
evident abscess 20 26 14 20
Kyphosis 84 85 81 84
Limitation of movement 96 91 97 95
Myelopathy (Independent
assessment)* 5 6 9 7
Site of lesion @
Thoracic 34 37 41 37
Thoraco-lumbar 15 15 10 13
Lumbar 44 44 40 42
Lumbo-sacral 7 5 9 7
Mediastinal or psoas
abscess shadow@ 57 56 57 57
Total patients 82 82 86 250
* On admission or within first 2 months of chemotherapy
@ Independent radiographic assessments (GW)
Re-treatment during Follow-up Period
No patient had reactivation of the spinal lesion during,
the five-year period of follow-up.
Sinuses and/or Clinically-evident Abscesses
In all, 49 (20% - 16 Rad 6, 21 Amb 6, 12 Amb 9) of
the 250 patients had one or more sinuses and/or clinically
evident abscesses on admission. By the end of treatment,
the sinus and/or abscess had resolved in 15 of the 16
patients in the Rad 6 series and 29 of the 33 in the
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combined ambulatory series. The resolution was slower
in the two ambulatory series. By 21 months all 49 had
resolved, without additional chemotherapy or surgery.
Sinuses and/or clinically evident abscesses were observed
for the first time after the start of chemotherapy in 32
(5 Rad 6, 12 Amb 6, 15 Amb 9) patients. The difference
between the Rad 6 and the combined ambulatory series
was significant (P=0.05). Of these, the lesions in 22 (4
Rad 6, 6 Amb 6, 12 Amb 9) patients had resolved by
the end of treatment and in all by 60 months. The detailed
findings are reported elsewhere (16).
Mediastinal Abscesses
A total of 66 patients (20 Rad 6, 22 Amb 6, 24 Amb
9) had radiographically visible mediastinal abscesses on
admission but no clinical evidence of sinus or abscess
at any time during the five-year period. The abscesses
had resolved without any intervention by 3 months in
13, 6 and 4, respectively, by 36 months in all except
3 (1 Amb 6, 2 Amb 9) and in 1 more (Amb 6) by 60
months (Rani et al, In Prep.).
Nervous System Involvement
Patients with myelopathy (defined as damage to or disease
of the spinal cord) secondary to the spinal lesion were
classified as having (a) functional impairment, or (b) no
functional impairment (i.e. with abnormal physical signs
only). Myelopathy was present on admission or devel-
oped within the first 2 months in 17 (7%) patients (4
Rad 6, 5 Amb 6, 8 Amb 9) including 11 (2 Rad 6, 5
Amb 6, 4 Amb 9) who had functional impairment.
The myelopathy resolved completely without additional
chemotherapy or surgery in 11 (2 Rad 6, 2 Amb 6, 7
Amb 9), and resolved by 36 months with additional
surgery with or without chemotherapy in 4 (3 Amb 6,
1 Amb 9); 1 (Rad 6) patient died with persisting functional
impairment and in 1 (Rad 6) the myelopathy initially
resolved by 9 months, recurred without functional im-
pairment but again resolved by 42 months. Thus all 16
patients alive at 5 years had no myelopathy for the first
time 2 months after the start of treatment but it had
resolved by 42 and 15 months, respectively.
Bony Fusion
The rate of occurrence of bony fusion was similar in the
3 series. In approximately two-thirds of the patients, there
w s complete bony fusion by 36 months (Table 2). At
5 y ars, 77%, 75% and 74% had complete bony fusion,
21%, 15% and 18% had partial fusion and 3%, 10% and
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Table 2 : Cumulative occurrence of complete bony fusion
Trt. Pts.
series assessed Complete bony fusion (months)
Partial
fusion
at 60
No
fusion
at 60
Rad 6 77
Amb 6 77
Amb 9 85
months months
0—12 0—24 0—36 0—48 0—60
No. % No. % No. % No. % No. % No. % No. %
26 34 42 55 50 65 53 69 59 77 16 21 2 3
26 33 41 52 52 66 55 70 59 75 12 15 8 10
25 29 43 51 49 58 56 66 63 74 15 18 7 8
8% had no fusion, respectively, in the Rad 6, Amb 6
and Amb 9 series.
Status at 60 months
V e r t e b r a l  B o d y - l o s s
On admission, the mean total vertebral body loss was
0.77 in 75 Rad 6, 0.83 in 75 Amb 6 and 0.65 in 82 Amb
9 patients (Table 3). The mean increase in vertebral body
loss was 0.18, 0.34 and 0.24, respectively, in the 3 series
during the 5-year period, indicating more loss of vertebral
bodies in the two ambulatory series than in the surgical
series, the difference being statistically significant (P=0.02).
Angle of Kyphosis
Regarding the angle of kyphosis on admission, the mean
angle was 26.5° for 34 Rad 6, 28.2° for 45 Amb 6 and
25.2° for 50 Amb 9 patients in the 3 series (Table 3)
which increased by 10.0°, 11.9° and 10.7°, respectively,
during the course of five years. Thus the increases in
the angle of kyphosis were similar, indicating no benefit
by surgery.
At 60 months, 72 (88%) of the 82 Rad 6, 75 (91%) of
the 82 Amb 6 and 84 (98%) of the 86 Amb 9 patients
were classifiedas having a favourable status, that is, they
had no sinus or clinical abscess present, no myelopathy
and had had no additional operation or chemotherapy
and no modification of the allocated regimen; they also
had no limitation of physical activity due to the spinal 
lesion and their disease was radiographically quiescent
(Table 4). The result in the Amb 9 series is significanty
better than in the Rad 6 series (P=0.03). A further 2%,
2% and 1%, respectively, were clinically favourable but
were classified as still not favourable solely because
radiographically their disease was not yet considered to
be quiescent. Eight (10%) of 82 Rad 6 patients were
classified as unfavourable as compared with 5 (6%) of
82 Amb 6 and 1 (1%) of 86 Amb 6 patients, the total
with an unfavourable status being 14 (6%) of the 250
patients. The 2 Rad 6 patients in whom operation had
been abandoned for technical reasons died in the 25th
Table 3 : Assessments of total vertebral body loss and angle of kyphosis
Mean vertebral body loss/ Mean increase in vertebral body
Assessment Site of lesion Regimen Total Pts. angle of kyphosis on loss/angle during (months)
admission
0—-36 36—60 0—60
Total Rad 6 75 0.77 0.18 0.00 0.18
vertebral Any Amb 6 75 0.83 0.30 0.04
0.34
body loss Amb 9 82 0.65 0.20 -0.03 0.24
=================================================================================================================
Angle of Thoracic of Rad 6 34 26.5º 10.2º -0.2º 10.0º
kyphosis* thoraco Amb 6 45 28.2º 13.5º -1.6º 11.9º
lumbar Amb 9 50 25.2º 10.0º 0.7º 10.7º
* Patients with lordotic angles or with a lesion extending below L2 are not included.
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and 28th months, both from non-tuberculous causes and
with a favourable status at the last attendance before
death.
Table 4 : Status at 60 months
Rad 6 Amb 6 Amb 9
No. % No. % No. %
Favourable* 72 88 75 91 84 98
Still not favourable
Not quiescent
radiographically 2 2 2 2 1 1
Unfavourable
Death due to or
associated with spinal
tuberculosis @ 4 0 0
Additional surgery 2 1 1
Additional surgery
and chemotherapy 0 10 2 6 0 1
Additional chemothe-
rapy 0 2 0
Radical operation
abandoned for
technical reasons 2 0 0
Tpta; 82 100 82 99 86 100
* As defined in the taxt (page 9)
@ Including one patient who had additional chemotherapy for myelopathy
and later died because of causes associated with spinal tuberculosis.
Progress of Patients Excluded from the Main Analyses
A total of 54 patients were excluded from the main
analyses. Of these, 41 were considered to have evidence
of active spinal tuberculosis. Seventeen patients were not
followed up to five years (14 died from other causes with
no evidence of activity of the spinal disease at the last
assessment, 2 had refused surgery, 1 defaulted).
Of the other 24 patients, 16 (7 Rad 6, 4 Amb 6, 5 Amb
9) had an uneventful progress during the 5 years. In the
remaining 8 (3 Rad 6, 2 Amb 6, 3 Amb 9) treatment
was changed in 1 (hepatic toxicity) and the allocated
chemotherapy was extended in 2 (tuberculosis of the hip-
1; active paraplegia-1). The remaining 5 patients had
treatment re-started during 3 to 5 years, 1 for reactivation
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of spinal tuberculosis, and 4 for extra-spinal tuberculosis,
namely, pulmonary tuberculosis-2; cervical-1 and me-
senteric adenitis-1.
DISCUSSION
An earlier publication from this Centre (ICMR, 1989)
had reported the results up to 3 years of ambulatory
chemotherapy with daily isoniazid plus rifampicin for
6 or 9 months compared with the same chemotherapy
for 6 months combined with radical resection (the modified
“Hong Kong” operation) in the treatment of spinal tu-
berculosis. In brief, at 3 years, ambulatory chemotherapy
for 9 months gave the best results, 96% of 92 Amb 9
patients attaining a favourable status, compared with 80%
of 85 Rad 6 (P=0.003) and 87% of 83 Amb 6 patients
(P=0.07). In all, only 15 (6%) of a total of 260 patients,
belonging to all 3 series, had an unfavourable status.
At five years, 98% of 86 Amb 9, 91% of 82 Amb 6 and
88% of 82 Rad 6 patients had a favourable status, the
difference between the Amb 9 and the Rad 6 series being
significant (P=0.03). In all, 14 (6%) of the 250 patients
in the 3 series were classified as having an unfavourable
response. More importantly, 4 (5%) of 82 Rad 6 patients
died due to reasons associated with their spinal disease,
compared with none of 168 patients of the two ambulatory
series combined. Thus the promising results at 3 years
were maintained or improved at 5 years. The two am-
bulatory regimens were highly effective in the treatment
of spinal tuberculosis, and apparently radical surgery did
not enhance the efficacy.
Studies conducted in Korea and Rhodesia showed that
ambulatory chemotherapy for 18 months with daily isoniazid
plus PAS (with or without an initial streptomycin sup-
plement) was very effective, 87% of 250 patients having
a favourable status at 5 years (MRC-1976, 1978). In a
concurrent comparison in Korea, a favourable status on
the allocated regimen was observed in 82% of 65 and
75% of 71 with 6- and 9- month regimens of isoniazid
plus rifampicin daily, respectively, compared with 79%
of 67 with an 18-month regimen of isoniazid plus PAS
or ethambutol daily (MRC-1993). It may be concluded
that ambulatory chemotherapy for 6 or 9 months with
daily isoniazid plus rifampicin is as highly effective as
ambulatory chemotherapy for 18 months withdaily isoniazid
plus PAS.
The radical surgery has been investigated in studies at
Hong Kong. It was combined with 18 months of daily
isoni zid plus PAS supplemented with daily streptomycin
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for 3 months (1st study) or with a 6- or 9-month regimen,
the regimens being similar to the Rad 6 of the present
study, but supplemented with twice-weekly streptomycin
for 6 months and the duration of the latter regimen being
9 months (2nd study). The overall results were excellent
in both the studies, 89% of 61 patients on the 18-month
regimen, and 96% of 50 patients on the 6- and 9- month
regimens combined having a favourable status at 5 years,
respectively, on the allocated regimen (MRC-1978, In
Prep.). Further, there were no deaths due to spinal disease
among a total of 112 patients who had this surgery.
Considering the Hong Kong patients, who underwent
radical surgery, complete bony fusion occurred in 92%
of 60 patients by 5 years (1st study-18 month regimen)
and in all (100%) of 50 patients of the 6- and 9- month
regimens combined (2nd study -MRC-1978, In Prep.).
In the present study the only benefits conferred by the
radical surgery were associated with sinus and/or clini-
cally evident abscess and mediastinal abscess. The speed
of resolution of these lesions was significantly greater
in the surgery series than in the two ambulatory series
(Rani et al, In Prep.). Moreover, the incidence of sinus
and/or clinically evidence abscess was significantly less
in the Rad 6 than in the combined Amb series (P=0.05).
Similar observations were made regarding sinuses and/
or clinically evident abscesses in studies conducted in
Korea and elsewhere, the chemotherapy being 18 months
of daily isoniazid plus PAS (MRC-1973 a, 1974 a, 1974
b). These findings suggest that though radical surgery
did not increase the proportion with a favourable status,
it resulted in some benefits.
Patients with myelopathy severe enough to prevent them
from walking across a room (about 6 meters) were not
admitted to the study. However, those with paraparesis
(but still able to walk) were admitted. In all, 19 (8%)
of 250 patients had myelopathy either initally (17 pa-
tients) or developed it subsequently (2 patients) in the
5-year period. Myelopathy resolved in 14 patients on the
allocated regimen and in 4 (3 Amb 6, 1 Amb 9) after
additional surgery or chemotherapy; the other patient
died with functional impairment. Other studies have shown
that of 41 patients receiving 18 months of chemotherapy
and having myelopathy during a 5-year period, the lesion
resolved in 36 (MRC-1976, 1978), including 27 on the
allocated regimen.
To sum up, when assessed at 5 years, ambulatory che-
motherapy with daily isoniazid and rifampicin for 6 or
9 months was highly effective in spinal tuberculosis, a
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favourable status on the allocated regimens being ob-
se ved in 91% and 98%, respectively. Radical surgery
did not enhance the efficacy. It may be concluded that
spinal tuberculosis can be successfully treated in the great
majority of patients with short-course chemotherapy on
an out-patient basis. Radical surgery, if at all necessary
for a select few, can be done in specialised spinal centres,
wher  all facilities are available. These findings are of
great relevance to the developing countries.
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